Cancer patients' motives for psychosocial consultation —Oncology social workers' perceptions of 226 patient cases

ConclusionsThe results show that Swedish OSWs' function is multifaceted and that the initial motives among patients rarely predict the content in consultations over time. Based on the diversity of motives, it seems obvious that OSWs (at least in Sweden) need a broad education in the psychology of counselling. It also seems obvious that even if patients initially were referred by health care staff to the OSW due to psychological reactions to being ill, staff should also be attentive to the fact that relational and socio‐economic/juridical issues are of great concern for the patients.
Source: Psycho-Oncology - Category: Cancer & Oncology Authors: Tags: PAPER Source Type: research

Related Links:

A video of the very sweet moment a young Tennessee girl learned she was cancer-free has gone viral.
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Authors: Emmanuel S, Jornayvaz FR Abstract Discovered 20 years ago, Fibroblast Growth Factor (FGF) 19, and its mouse ortholog FGF15, were the first members of a new subfamily of FGFs able to act as hormones. During fetal life, FGF15/19 is involved in organogenesis, affecting the development of the ear, eye, heart and brain. At adulthood, FGF15/19 is mainly produced by the ileum, acting on the liver to repress hepatic bile acid synthesis and promote postprandial nutrient partitioning. In rodents, pharmacologic doses of FGF19 induce the same anti-obesity and anti-diabetic actions as FGF21, these metabolic effects bei...
Source: Endocrine Reviews - Category: Endocrinology Tags: Endocr Rev Source Type: research
STEFAN KARL STEFANSSON, the LazyTown actor that starred as Robbie Rotten, has died after a battle with bile duct cancer. Bile duct cancer symptoms include  itchy skin and weight loss - these are the warning signs to look out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Timmerman C, Taveras L, Huerta S Abstract INTRODUCTION: The standard of care for locally advanced rectal cancer includes neoadjuvant chemoradiation with subsequent total mesorectal excision. This approach has shown various degrees of response to neoadjuvant chemoradiation (ranging from complete response to further tumor growth), which have substantial prognostic and therapeutic implications. A total regression of the tumor is a predictor of superior oncologic outcomes compared to partial and non-responders. Further, this concept has opened the possibility of nonoperative strategies for complete responders ...
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Tags: Expert Rev Mol Diagn Source Type: research
Authors: El-Chaer WK, Moraes CF, Nóbrega OT Abstract Although prostate cancer (PCa) is the sixth most common type of neoplasm in the world and the second in prevalence among men (10% of all cases), there is shortage of studies focused on primary prevention of the disorder as well as little understanding on its pathophysiology. Currently, the PCa screening tools are the prostate specific antigen (PSA) dosage conjugated to rectal examination and confirmed by prostate biopsy. Despite the name, the PSA presents reduced specificity, being necessary the identification of new biomarkers that allow an earlier and mo...
Source: Journal of Aging Research - Category: Geriatrics Tags: J Aging Res Source Type: research
In recent years, researchers working on forms of telomerase gene therapy have produced evidence to show that increased levels and activity of telomerase does not raise cancer risk in mice. The open access paper and publicity materials noted below report the latest example. Extra telomerase increases the sort of activities that are beneficial in the context of improved regenerative capacity, but might be thought to raise the risk of cancer when they take place in the damaged environment of old tissue. This means more stem cell activity, more cellular replication, and so forth. Somatic cells are limited in the degree ...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
SAN FRANCISCO - A California jury on Aug. 10 found that Monsanto Co. acted with malice regarding its failure to warn of the damages associated with glyphosate, the active ingredient in Roundup, and awarded $289,254,882.32 in damages in the bellwether case of a man who said his repeated exposure to the herbicide caused his cancer (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - The California judge who presided over the trial in which a jury awarded $289 million to a man who said Monsanto Co. was liable for causing his cancer as a result of exposure to glyphosate confirmed Aug. 17 that the verdict was unanimous and that she was not expressing a vote when she polled the jury, as has been claimed by a Monsanto executive in an interview with the British Broadcasting Co. (BBC).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO - The attorney representing a California man who contends that he developed cancer as a result of exposure to glyphosate on Aug. 7 presented closing arguments in the first trial related to the herbicide Roundup and asked a jury to "change the world" by holding Monsanto Co. accountable for its "reckless disregard for human health," which he said warranted an award of more than $412.25 million in combined damages (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SACRAMENTO, Calif. - The California Supreme Court on Aug. 15 denied a petition for review filed by Monsanto Co., which contended that an appellate panel erred when it ruled in favor of the California Office of Environmental Health Hazard Assessment (OEHHA), which listed glyphosate as a carcinogen (Monsanto Company v. Office of Environmental Health Hazard Assessment, et al., No. S249056, Calif. Sup.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
More News: Cancer | Cancer & Oncology | Education | Health Management | Psychology | Study | Sweden Health | Universities & Medical Training